APA (7th ed.) Citation

Manne, A., Sheel, A., Sara, A., Noonan, A. M., Yu, L., Yang, W., . . . Esnakula, A. K. (2024). Mucin 5 AC (MUC5AC) to predict pathologic treatment response (TR) to neoadjuvant chemotherapy (NAT) in resected-pancreatic ductal adenocarcinoma (R-PDA). Journal of Clinical Oncology, 42, 690-806. https://doi.org/10.1200/JCO.2024.42.3_suppl.690

Chicago Style (17th ed.) Citation

Manne, Ashish, et al. "Mucin 5 AC (MUC5AC) to Predict Pathologic Treatment Response (TR) to Neoadjuvant Chemotherapy (NAT) in Resected-pancreatic Ductal Adenocarcinoma (R-PDA)." Journal of Clinical Oncology 42 (2024): 690-806. https://doi.org/10.1200/JCO.2024.42.3_suppl.690.

MLA (8th ed.) Citation

Manne, Ashish, et al. "Mucin 5 AC (MUC5AC) to Predict Pathologic Treatment Response (TR) to Neoadjuvant Chemotherapy (NAT) in Resected-pancreatic Ductal Adenocarcinoma (R-PDA)." Journal of Clinical Oncology, vol. 42, 2024, pp. 690-806, https://doi.org/10.1200/JCO.2024.42.3_suppl.690.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.